Search Results - "BURBURY, Kate L"

Refine Results
  1. 1

    Ponatinib Tyrosine Kinase Inhibitor Induces a Thromboinflammatory Response by Hamadi, Abdullah, Grigg, Andrew P, Dobie, Gasim, Burbury, Kate L, Schwarer, Anthony P, Kwa, Faith A, Jackson, Denise E

    Published in Thrombosis and haemostasis (01-07-2019)
    “…Both nilotinib, a second-generation tyrosine kinase inhibitor (TKI) used in the treatment of chronic myeloid leukaemia (CML), and ponatinib, a third-generation…”
    Get more information
    Journal Article
  2. 2

    The tyrosine kinase inhibitor, nilotinib potentiates a prothrombotic state by Alhawiti, Naif, Burbury, Kate L, Kwa, Faith A, O'Malley, Cindy J, Shuttleworth, Peter, Grigg, Andrew P, Jackson, Denise E

    Published in Thrombosis research (01-09-2016)
    “…Abstract Tyrosine kinase inhibitors (TKI) such as imatinib, nilotinib and dasatinib are now established as highly effective frontline therapies for chronic…”
    Get full text
    Journal Article
  3. 3
  4. 4

    A protocol for prospective observational study to determine if non-anaemic iron deficiency worsens postoperative outcome in adult patients undergoing elective cardiac surgery: the IDOCS study by Miles, Lachlan F, Soo, Vanessa Pac, Braat, Sabine, Heritier, Stephane, Burbury, Kate L, Story, David A

    Published in Perioperative medicine (London) (08-02-2022)
    “…Pre-operative anaemia has been associated independently with worse outcomes after cardiac surgery in adults and is often caused by absolute or functional iron…”
    Get full text
    Journal Article
  5. 5

    Associations between non-anaemic iron deficiency and outcomes following elective surgery for colorectal cancer: a prospective cohort study by Miles, Lachlan F, Luu, Sarah, Ong, Ian, Pac Soo, Vanessa, Braat, Sabine, Burgess, Adele, Heritier, Stephane, Tan, Nicole, Parker, Anna, Richards, Toby, Burbury, Kate L, Story, David A

    Published in Anaesthesia (15-10-2024)
    “…Iron deficiency is present in up to 75% of patients presenting for colorectal cancer surgery. It is unclear whether iron deficiency without anaemia is…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Associations between non-anaemic iron deficiency and outcomes following elective cardiac surgery (IDOCS): a prospective cohort study by Miles, Lachlan F, Pac Soo, Vanessa, Braat, Sabine, Bade-Boon, Jordan, Heritier, Stephane, Klein, Andrew A, Myles, Paul S, Richards, Toby, Symons, Joel, Burbury, Kate L, Story, David A

    Published in The Lancet. Haematology (01-07-2022)
    “…BACKGROUNDOne in two adults undergoing cardiac surgery are iron deficient, best practice guidelines and consensus statements recommend routine investigation…”
    Get full text
    Journal Article
  10. 10

    Short‐term warfarin reversal for elective surgery – using low‐dose intravenous vitamin K: safe, reliable and convenient by Burbury, Kate L., Milner, Alvin, Snooks, Belinda, Jupe, David, Westerman, David A.

    Published in British journal of haematology (01-09-2011)
    “…Summary Peri‐procedural management of warfarin reflects an intricate balance between the restoration of haemostasis and appropriate thromboprophylaxis. This…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Role of flow cytometry in myelodysplastic syndromes: diagnosis, classification, prognosis and response assessment by Burbury, Kate L., Westerman, David A.

    Published in Leukemia & lymphoma (01-04-2014)
    “…Abstract Myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid neoplasms. With the emergence of therapeutic options, attempts to standardize…”
    Get full text
    Journal Article
  13. 13

    Recommendations for the use of pegylated interferon‐α in the treatment of classical myeloproliferative neoplasms by Forsyth, Cecily J., Chan, Wai‐Hoong, Grigg, Andrew P., Cook, Nathalie C., Lane, Steven W., Burbury, Kate L., Perkins, Andrew C., Ross, David M.

    Published in Internal medicine journal (01-08-2019)
    “…The classical myeloproliferative neoplasms (MPN) are uncommon clonal haemopoietic malignancies characterised by excessive production of mature blood cells…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Thromboembolism During Neoadjuvant Therapy for Gastrointestinal Cancer by SMART, Philip J, BURBURY, Kate L, LYNCH, A. Craig, MACKAY, John R, HERIOT, Alexander G

    Published in American journal of clinical oncology (01-12-2014)
    “…Thromboembolism a common, costly, and morbid complication that is also associated with decreased survival in cancer patients. The risk of thromboembolism in…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Flow cytometry (FCM) in myeloid malignancies by Westerman, David A., Lee, Denise, Burbury, Kate L.

    Published in Pathology (2014)
    “…Myelodysplasic syndromes (MDS) and acute myeloid leukaemia (AML) are the predominant myeloid neoplasms where FCM has both a diagnostic and prognostic role in…”
    Get full text
    Journal Article